GlobalData Analyst reveals two key issues in Asthma Treatment worldwide
World Asthma Day saw an uproar in UK media attention due to the National Review of Asthma Deaths (NRAD), published by the Royal College of Physicians, which revealed that due to substandard physician education, doctors and nurses were unable to recognize signs of poor asthma control; however, several other unmet needs must be addressed globally, says an analyst with research and consulting firm GlobalData.
A number of official sources estimate that up to 5.4 million people in the UK are currently receiving treatment for asthma, and the NRAD reported that 1,200 die annually of the disease. Spain and Italy have approximately half the asthma mortality rate of the UK, while asthma prevalence in these two countries is also about half of that in the UK.
According to Valentina Gburcik, Ph.D., GlobalData's Senior Analyst covering Cardiovascular & Metabolic Disorders, the NRAD report failed to consider that the prevalence of asthma in the UK is among the highest in the world, so the number of asthma-related deaths is also naturally much higher.
The analyst continues: “Deeper comparative research into the epidemiology of asthma therefore needs to be done in order to demonstrate clearly what percentage of asthmatics die across different countries. Only then can reliable conclusions on the influence of different healthcare systems on asthma-related deaths be made.”
Additionally, Gburcik says that there are other key issues in asthma treatment, such as the heterogeneous nature of the disease, a lack of patient compliance with the standard therapies, and the high cost of medications.
The analyst says: “The economic burden of asthma is among the highest for non-communicable diseases in every country, and who bears these costs depends on the source of healthcare funding. Regardless of whether these costs are covered directly by patients, taxpayers or insurance companies, the high price of asthma medications is putting many lives at risk.”
Gburcik believes that lowering the cost of asthma medications and instituting a more personalized approach to treatment would lead to greater patient compliance and a reduced number of hospitalizations globally.
Vuram launches automated app to track COVID-19 supplies
A new app that tracks COVID-19 supplies in real time time has launched.
Built by hyper-automation services company Vuram, Trackable can monitor the progress of vaccines, oxygen cylinders, PPE, and masks as they move through the supply chain.
The app's features include street view to facilitate coordination between drivers, and trained facial recognition software powered by Microsoft Azure to ensure goods are only handled by authorised personnel.
Other functions include:
* Demand management for inventories, to prioritise deliveries using automation
* Demand analysis to predict sales trends based on stock levels
* Offline multilingual feature for drivers
* A dashboard to see the status and location of drivers
* Insights on how products are performing in real-time
The team at Vuram built Trackable as part of the Appian World 2021 Online Hackathon, where participants can take their ideas for innovative software and create a custom app. The tracking app went on to win the contest.
“Custom component building is at the heart of this application, and we focussed on making them more creative to provide an improved user experience" said Santosh Kumar, co-developer of Trackable.
"We are happy that we have managed to make it to the top in just a month. On behalf of Vuram, I thank the Appian Hackathon team for their efforts in conducting the event, and my hearty congratulations to all the winners."